MIGLUMIR — PRODUCTIONS FOR BIOPHARMACEUTICAL DEPARTMENT (Q4050672)

From EU Knowledge Graph
Revision as of 06:15, 27 January 2022 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in en, and other parts: Adding English translations)
Jump to navigation Jump to search
Project Q4050672 in Italy
Language Label Description Also known as
English
MIGLUMIR — PRODUCTIONS FOR BIOPHARMACEUTICAL DEPARTMENT
Project Q4050672 in Italy

    Statements

    0 references
    75,000.0 Euro
    0 references
    150,000.0 Euro
    0 references
    50.0 percent
    0 references
    SERICHIM S.R.L.
    0 references
    0 references
    IL PROGETTO HA L¿OBBIETTIVO DI VERIFICARE I PROCESSI DI PRODUZIONE DI TRE PRODOTTI, IL MIGLUSTAT (API), LA TRIPSINA IMMOBILIZZATA, CATALIZZATORE PER LA SINTESI DI DETEMIR E SUCCINIMIDIL MIRISTATO (MIR-OSU), INTERMEDIO AVANZATO PER LA SINTESI DI DETEMIR, A PARTIRE DA TECNOLOGIE DI BASE ACQUISITE (Italian)
    0 references
    THE PROJECT AIMS TO VERIFY THE PRODUCTION PROCESSES OF THREE PRODUCTS, MIGLUSTAT (API), IMMOBILISED TRYPSIN, CATALYST FOR THE SYNTHESIS OF DETEMIR AND SUCCINIMIDIL MYRISTAT (MIR-OSU), ADVANCED INTERMEDIATE FOR THE SYNTHESIS OF DETEMIR, STARTING FROM ACQUIRED BASIC TECHNOLOGIES (English)
    27 January 2022
    0 references
    TORVISCOSA
    0 references

    Identifiers